Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
about
Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Healthcare Cost and Utilizatio ...... sis Bronchiectasis in the U.S.
@en
Healthcare Cost and Utilizatio ...... sis Bronchiectasis in the U.S.
@nl
type
label
Healthcare Cost and Utilizatio ...... sis Bronchiectasis in the U.S.
@en
Healthcare Cost and Utilizatio ...... sis Bronchiectasis in the U.S.
@nl
prefLabel
Healthcare Cost and Utilizatio ...... sis Bronchiectasis in the U.S.
@en
Healthcare Cost and Utilizatio ...... sis Bronchiectasis in the U.S.
@nl
P2093
P2860
P356
P1476
Healthcare Cost and Utilizatio ...... sis Bronchiectasis in the U.S.
@en
P2093
Christopher M Blanchette
Douglas Mapel
Emily Zacherle
Glenda Stone
Joshua M Noone
Reuben Howden
Ripsi P Patel
P2860
P356
10.3390/MEDSCI5040020
P577
2017-09-23T00:00:00Z